p16 as a prognostic indicator in ovarian/tubal high-grade serous carcinoma-Reference-Cited by-同舟云学术

p16 as a prognostic indicator in ovarian/tubal high-grade serous carcinoma

Published:2015-09-13 Issue:4 Volume:68 Page:615-618
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Beirne James P¹²,McArt Darragh G³,James Jacqueline A⁴,Salto-Tellez Manuel⁴,Maxwell Perry⁴,McCluggage W Glenn¹²⁵

Affiliation:

1. Ovarian Cancer Research Focus Group; Centre for Cancer Research and Cell Biology; Queen's University; Belfast Northern Ireland

2. Northern Ireland Gynaecological Cancer Centre; Belfast City Hospital; Belfast Health and Social Care Trust; Belfast Northern Ireland

3. Department of Bioinformatics; Centre for Cancer Research and Cell Biology; Queen's University; Belfast Northern Ireland

4. The Northern Ireland Molecular Pathology Laboratory; Centre for Cancer Research and Cell Biology; Queen's University Belfast and The Belfast Health and Social Care Trust; Belfast Northern Ireland

5. Department of Pathology; Royal Victoria Hospital; Belfast Health and Social Care Trust; Belfast Northern Ireland

Funder

HSC Research and Development Division of the Public Health Agency

Belfast CR-UK Centre

Northern Ireland Experimental Cancer Medicine Centre

Cancer Research UK

Friends of the Cancer Centre

Sean Crummey Foundation

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/his.12777/fullpdf

Reference4 articles.

1. Retinoblastoma pathway deregulatory mechanisms determine clinical outcome in high-grade serous ovarian carcinoma;Milea;Mod. Pathol.,2014

2. High-grade ovarian serous carcinoma exhibits significantly higher p16 expression than low-grade serous carcinoma and serous borderline tumour;O'Neill;Histopathology,2007

3. Increased p16 expression in high-grade serous and undifferentiated carcinoma compared with other morphologic types of ovarian carcinoma;Phillips;Int. J. Gynecol. Pathol.,2009

4. BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer;Carser;Gynecol. Oncol.,2011

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Fine Needle Aspiration Cytology in the Diagnosis of Gynecologic Tumors;Acta Cytologica;2023

2. Serous Tumors, Pathology of the Ovary;Encyclopedia of Pathology;2023

3. Serous Tumors of the Ovary;Encyclopedia of Pathology;2022-12-28

4. Neuroendocrine Carcinoma of the Uterine Cervix: A Clinicopathologic and Immunohistochemical Study with Focus on Novel Markers (Sst2–Sst5);Cancers;2020-05-12

5. Cryobiopsy during flex-rigid pleuroscopy: an emerging alternative biopsy method in malignant pleural mesothelioma. A comparative study of pathology;Japanese Journal of Clinical Oncology;2019-03-11